Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;14(3):167-74.
doi: 10.4048/jbc.2011.14.3.167. Epub 2011 Sep 29.

Heat shock protein as molecular targets for breast cancer therapeutics

Affiliations

Heat shock protein as molecular targets for breast cancer therapeutics

Lee Su Kim et al. J Breast Cancer. 2011 Sep.

Abstract

Recent advances in the understanding of the molecular mechanisms involved in the breast cancer development and progression have led to the identification of numerous novel molecular targets. Among these, heat shock proteins (HSPs) are being emerging molecular target due to its diverse function in cancer cells. HSPs are highly conserved molecular chaperone that are synthesized by cell in response to various stress conditions. Mammalian HSPs have been classified into several families according to their molecular weight: HSP100, HSP90, HSP72, and small molecular HSPs (including HSP27). They are essential proteins that play a key role in cell survival through the cytoprotective mechanisms. In addition, HSPs are often overexpressed in a rage of cancers including breast cancer, and its overexpression seems to be associated with poor clinical outcomes. Also, HSP90 play a role in facilitating transformation by stabilizing the mutated and overexpressed oncoproteins found in breast cancer cell. Pharmacological targeting of HSP is therefore indicated and in the case of HSP90, numerous inhibitory drugs are undergoing clinical trial for treatment of breast cancer and other cancers. In this review, we describe the roles of HSPs in cancer cell and introduce the HSPs inhibitor as molecular target in cancer therapy and its recent clinical trials in breast cancer.

Keywords: Breast; Carcinoma; Chaperone; Heat; Shock.

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
HSP70/90 expression on breast cancer cell lines using Western blot assay. Expression of HSP70/90 are observated in both hormone receptor positive cell lines (1: MDA-MB 435; 2: MDA-MB 231) and hormone receptor negative cell lines (6: MCF-7; 7: T-47D). Also, MDA-MB 231LC3 (3), MDA-MB 231GFP (4), and MDA-MB 231BR3 cell line (5) expressed HSP70/90 proteins.
Figure 2
Figure 2
The effect of geldanamycin on breast cancer cell lines measured by MTT assay. Compared with DMSO and control group, gendanamycin markedly inhibited the cell growth in breast cancer cell lines in a dose-dependent manner.

References

    1. Workman P. Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone. Cancer Lett. 2004;206:149–157. - PubMed
    1. Workman P, Burrows F, Neckers L, Rosen N. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci. 2007;1113:202–216. - PubMed
    1. Neckers L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med. 2002;8(4 Suppl):S55–S61. - PubMed
    1. Ritossa F. A new puffing pattern induced by temperature shock and DNP in drosophila. Cell Mol Life Sci. 1962;18:571–573.
    1. Ritossa F. Discovery of the heat shock response. Cell Stress Chaperones. 1996;1:97–98. - PMC - PubMed